Harmony Biosciences Holdings, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $868.5 | $714.7 | $582.0 | $437.9 | $305.4 |
| Operating income | $208.5 | $190.8 | $192.0 | $120.2 | $87.5 |
| Net income | $158.7 | $145.5 | $128.9 | $181.5 | $34.6 |
| Balance Sheet | |||||
| Total debt | $165.0 | $181.2 | $196.2 | $197.5 | $199.5 |
| Cash Flow Statement | |||||
| Free cash flow | $347.9 | $218.7 | $219.1 | $144.3 | $98.3 |
| Share repurchases | — | — | $100.0 | — | — |
Shares outstanding 58.2M · Free float 74.0%
Annual filing data through FY ended December 31, 2025; float as of September 12, 2026.